Detalhe da pesquisa
1.
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.
Blood
; 142(25): 2192-2197, 2023 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37616555
2.
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.
Blood
; 139(26): 3737-3751, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443029
3.
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Blood
; 140(21): 2228-2247, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130297
4.
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.
EMBO Rep
; 23(4): e52904, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35156745
5.
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies.
Value Health
; 27(5): 607-613, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311180
6.
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies.
Intern Med J
; 54(2): 328-336, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146232
7.
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha.
Br J Haematol
; 202(6): 1127-1136, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482935
8.
Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia.
Blood
; 137(9): 1196-1207, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871588
9.
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.
Haematologica
; 108(9): 2380-2395, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951160
10.
Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes.
Mol Pharm
; 20(8): 3937-3946, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463151
11.
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.
Nature
; 543(7647): 733-737, 2017 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329763
12.
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.
N Engl J Med
; 381(24): 2315-2326, 2019 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826340
13.
Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis.
Am J Hematol
; 97(11): 1464-1477, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802782
14.
Counterpoint: There is a best duration of deep molecular response for treatment-free remission, but it is patient-specific, and that is the challenge.
Br J Haematol
; 192(1): 24-27, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169882
15.
Persistence of myelofibrosis treated with ruxolitinib: biology and clinical implications.
Haematologica
; 106(5): 1244-1253, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33472356
16.
COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
Intern Med J
; 51(5): 763-768, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047035
17.
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells.
Br J Haematol
; 191(3): 433-441, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32352166
18.
Single cells tell multiple tales in CML.
Blood
; 141(22): 2668-2670, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37261852
19.
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.
Blood
; 132(9): 948-961, 2018 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29967129
20.
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.
Blood
; 141(9): 1087-1091, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574363